Report Categories
View AllRecent Articles
View All
RNW ReNew Energy Global plc shares climb 29 percent on 194 percent Q1 2026 revenue growth despite larger than expected losses
Clearmind CMND Stock Exits Position Rockets 20260416
IHRT iHeartMedia Inc shares rise nearly 10 percent even after posting a sharp fourth quarter 2025 earnings miss
Brinker International EAT Sector Leadership Brinker International Inc posts 82 EPS beat on strong diner demand
When Paycom Software PAYC Stock Will Rise 317 20260415
ConnectOne CNOB Stock Foreign Investment 235 20260418
Eaton EVG Stock Government Bond Ticks Lower 20260418
INVESCO IVR Stock Price Movement Behavior INVESCO MORTGAGE CAPITAL posts tiny 06 EPS miss
Rezolute RZLT Top Gainer Q1 2026 Earnings Underperform
RILYT BRC Group Holdings Inc 600 Senior Notes Due 2028 falls 206 after Q1 2024 earnings post 171 per share loss
Should I hold WiMi WIMI stock WiMi posts 2 EPS miss trailing analyst consensus forecast
Is Trinity TRIB stock a good opportunity today Q4 2024 EPS Misses Estimates
EFX Equifax delivers Q4 2025 modest earnings beat 69 percent annual revenue growth lifts shares
Sui Group SUIG Stock Exit Signals Pressure Mounts 20260420
Digital Realty Trust Inc DLR
Is Repay RPAY stock overvalued today Repay posts 113 EPS miss amid mounting cost pressures
Is Niagen Bioscience NAGE stock holding under pressure Near Lows 20260420
Southern Co SO Remains Top Allocation in T Rowe Price Equity Income Funds 2026 Q1 Portfolio Rebalance
MetaVia MTVA Stock Asset Based Valuation Smart Money Exits 20260420
PPL PPLC Stock Is It Near Breakout 076 20260420
Why Birks BGI Stock Matters 154 20260420
Exclusive Seized Iranian Vessel Suspected of Carrying Undeclared DualUse Equipment Market Data Shows
Otis OTIS Stock Trendline Structure Analysis Otis posts 23 EPS miss amid high cost pressures
ZVRA Zevra Therapeutics delivers massive Q4 2025 EPS beat but shares dip modestly in daily trading
ZOOZ Strategy ZOOZ Stock Market Sentiment Analysis 774 20260420
ATRC AtriCure delivers big Q4 2025 earnings upside shares rise 379 percent on upbeat investor reaction
SYRE Spyre Therapeutics reports narrower Q4 2025 pershare loss than consensus forecasts with shares edging higher in todays trading
Illumina Inc ILMN DRAGEN v45 Launch Expands Genomic Workflow Capabilities Positions Firm for Accelerated Recurring Revenue Growth